TY - JOUR
T1 - Sequencing [4 + 1]-Cycloaddition and Aza-Michael Addition Reactions
T2 - A Diastereoselective Cascade for the Rapid Access of Pyrido[2′,1′:2,3]/Thiazolo[2′,3′:2,3]imidazo[1,5- a]quinolone Scaffolds as Potential Antibacterial and Anticancer Motifs
AU - Srinivasulu, Vunnam
AU - Khanfar, Monther
AU - Omar, Hany A.
AU - Elawady, Raafat
AU - Sieburth, Scott Mc N.
AU - Sebastian, Anusha
AU - Zaher, Dana M.
AU - Al-Marzooq, Farah
AU - Hersi, Fatema
AU - Al-Tel, Taleb H.
N1 - Publisher Copyright:
Copyright © 2019 American Chemical Society.
PY - 2019/11/15
Y1 - 2019/11/15
N2 - The design and synthesis of a quality compound library containing a small number of skeletally diverse scaffolds, whose members rapidly deliver new chemical probes active against multiple phenotypes, is paramount in drug discovery. In this context, an efficient one-pot strategy for the synthesis of a mini library of sp3-enriched hexahydropyrido[2′,1′:2,3]imidazo[1,5-a]quinolinium and hexahydrothiazolo[2′,3′:2,3]imidazo[1,5-a]quinolinium architectures, is described. This new one-pot method features a combination of Sc(OTf)3-catalyzed [4 + 1]-cycloaddition with aza-Michael addition reactions. The cascade results in a rapid and diastereoselective formation of these scaffolds via desymmetrization of the oxidative dearomatization products of phenols. Phenotypic screening of the mini library against multiple drug-resistant bacteria and a panel of cancer cell lines identified potential antibacterial and anticancer lead drug candidates. Further investigation of the anticancer leads, indicated by their activity as tubulin-polymerization inhibitors, represents a promising approach for cancer therapy.
AB - The design and synthesis of a quality compound library containing a small number of skeletally diverse scaffolds, whose members rapidly deliver new chemical probes active against multiple phenotypes, is paramount in drug discovery. In this context, an efficient one-pot strategy for the synthesis of a mini library of sp3-enriched hexahydropyrido[2′,1′:2,3]imidazo[1,5-a]quinolinium and hexahydrothiazolo[2′,3′:2,3]imidazo[1,5-a]quinolinium architectures, is described. This new one-pot method features a combination of Sc(OTf)3-catalyzed [4 + 1]-cycloaddition with aza-Michael addition reactions. The cascade results in a rapid and diastereoselective formation of these scaffolds via desymmetrization of the oxidative dearomatization products of phenols. Phenotypic screening of the mini library against multiple drug-resistant bacteria and a panel of cancer cell lines identified potential antibacterial and anticancer lead drug candidates. Further investigation of the anticancer leads, indicated by their activity as tubulin-polymerization inhibitors, represents a promising approach for cancer therapy.
UR - http://www.scopus.com/inward/record.url?scp=85074576505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074576505&partnerID=8YFLogxK
U2 - 10.1021/acs.joc.9b01919
DO - 10.1021/acs.joc.9b01919
M3 - Article
C2 - 31633919
AN - SCOPUS:85074576505
SN - 0022-3263
VL - 84
SP - 14476
EP - 14486
JO - Journal of Organic Chemistry
JF - Journal of Organic Chemistry
IS - 22
ER -